Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06653725 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure

Study acronym: KETO-AHF
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 2 of 8 sitesv4
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 1, 2025 to Mar 20, 2025 · Site details revised at 8 of 8 sitesv3 Show 2 more changesShow less
    • Start date changed from estimate of Feb 1, 2025 to Mar 20, 2025
    • Site details revised at 8 of 8 sites
  3. Start date: Nov 1, 2024 to Feb 1, 2025 Eligibility criteria shortened, about 26 words · Secondary endpoints: 14 to 15v2 Show 2 more changesShow less
    • Eligibility criteria shortened, about 26 words
    • Secondary endpoints: 14 to 15

    See this version in full on ClinicalTrials.gov ↗

  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, randomized, double-blind, placebo-controlled trial to investigate the clinical efficacy of treatment with exogenous dietary ketone supplement containing 1,3-butanediol in patients hospitalized with acute heart failure (AHF), potentially leading to better clinical outcomes.
Trial Details
NCT Number NCT06653725
Lead Sponsor Aarhus University Hospital
Collaborators: Viborg Regional Hospital, Hospitalsenhed Vest, Herning, Odense University Hospital, Aalborg University Hospital, Rigshospitalet, Denmark, Copenhagen University Hospital at Herlev, Amager Hospital
Conditions Acute Heart Failure (AHF)
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov